Published May 8, 2026 | Version v1

Dataset related to the article "Low-Abundance Proteomics Reveal Pleiotrophin and Fibroblast Growth Factor-21 as Biomarkers of Metabolic Dysfunction-Associated Steatohepatitis"

  • 1. Centro Cardiologico Monzino IRCCS

Description

This record contains row data generate at Centro Cardiologico Monzino, related to the article "Low-Abundance Proteomics Reveal Pleiotrophin and Fibroblast Growth Factor-21 as Biomarkers of Metabolic Dysfunction-Associated Steatohepatitis"

Abstract

Metabolic dysfunction-associated steatotic liver disease (MASLD) is closely linked to comorbidities like obesity, type 2 diabetes, and cardiovascular disease. Given that liver biopsy is the diagnostic gold standard, there is a critical need for minimally invasive tests, particularly for the inflammatory form, metabolic dysfunction-associated steatohepatitis (MASH). In this discovery study, we investigated the plasma proteome to identify blood biomarkers for MASHandexplored their potential tissue sources, the liver and visceral adipose tissue. Plasma low-abundance proteome profiling was performed on samples from a cohort of morbidly obese MASLD subjects (n = 90; 40 with MASH, 50 without) using Olink® panels. Paired liver and visceral adipose biopsies were also analyzed. Data showed 34 significantly different plasma proteins between the two groups, including Pleiotrophin (PTN), Fibroblast growth factor-21 (FGF-21), and Hepatocyte growth factor (HGF), among others. While plasma-tissue correlation was only found for STX8, PTN and FGF-21 demonstrated the strongest associations with the histopathological features of MASH. A diagnostic model combining PTN, FGF-21, and AST achieved a robust AUC of 0.88 (95% CI: 0.84–0.97) for distinguishing MASH. Based on this discovery pilot study, circulating PTN and FGF-21 emerge as promising non-invasive biomarkers for improving patient stratification and supporting therapeutic evaluation in MASH, warranting validation in independent cohorts and future studies.

Files

Files (2.8 MB)

Name Size
md5:66b5acca32babfaa5b6359f91ca5f8c8
661.5 kB Download
md5:bec1d2752bcb8685d9754732d9a94c1b
100.2 kB Download
md5:98e47e3e1a1eefd5d5059bf06f72c9c6
669.5 kB Download
md5:6a5284db0d4eb27732ad6560e6c21501
671.8 kB Download
md5:d644fdb938e2ec6739e879a48e0f62ec
659.5 kB Download

Additional details

Related works

Is supplement to
Data paper: 10.3390/ ijms262210943 (DOI)

Funding

Ministero della Salute
Ricerca Corrente to Centro Cardiologico Monzino RC